| [1] |
PROF Y X, PROF J L, LI M, et al. Diabetes in China part 1: epidemiology and risk factors[J]. The Lancet Public Health, 2024, 9(12): e1089-e1097. DOI: 10.1016/S2468-2667(24)00250-0.
|
| [2] |
LI G C, YU Y F, LIN C Q, et al. Association between major depressive disorder or depressive symptoms and the risk of vascular complications among patients with type 2 diabetes, and the mediating role of metabolic biomarkers: an analysis of the UK biobank cohort[J]. EClinicalMedicine, 2024, 79: 102982. DOI: 10.1016/j.eclinm.2024.102982.
|
| [3] |
LLOYD C E, NOUWEN A, SARTORIUS N, et al. Prevalence and correlates of depressive disorders in people with Type 2 diabetes: results from the International Prevalence and Treatment of Diabetes and Depression(INTERPRET-DD)study, a collaborative study carried out in 14 countries[J]. Diabet Med, 2018, 35(6): 760-769. DOI: 10.1111/dme.13611.
|
| [4] |
PERRIN N E, DAVIES M J, ROBERTSON N, et al. The prevalence of diabetes-specific emotional distress in people with Type 2 diabetes: a systematic review and meta-analysis[J]. Diabet Med, 2017, 34(11): 1508-1520. DOI: 10.1111/dme.13448.
|
| [5] |
YEUNG Y L, LEE K L, LAU E S, et al. Associations of comorbid depression with cardiovascular-renal events and all-cause mortality accounting for patient reported outcomes in individuals with type 2 diabetes: a 6-year prospective analysis of the Hong Kong Diabetes Register[J]. Front Endocrinol(Lausanne), 2024, 15: 1284799. DOI: 10.3389/fendo.2024.1284799.
|
| [6] |
中华医学会糖尿病学分会.中国2型糖尿病防治指南(2020年版)[J]. 中华内分泌代谢杂志, 2021, 37(4): 311-398.
|
| [7] |
GLAVIN D, GRUA E M, NAKAMURA C A, et al. Patient health questionnaire-9 item pairing predictiveness for prescreening depressive symptomatology: machine learning analysis[J]. JMIR Ment Health, 2023, 10: e48444. DOI: 10.2196/48444.
|
| [8] |
XU W, JIANG W H, DING R J, et al. Study of rates and factors associated to psychosomatic syndromes assessed using the diagnostic criteria for psychosomatic research across different clinical settings[J]. Psychother Psychosom, 2024, 93(6): 386-396. DOI: 10.1159/000541404.
|
| [9] |
|
| [10] |
LIU X B, LI Y X, GUAN L, et al. A systematic review and meta-analysis of the prevalence and risk factors of depression in type 2 diabetes patients in China[J]. Front Med(Lausanne), 2022, 9: 759499. DOI: 10.3389/fmed.2022.759499.
|
| [11] |
LUO P, CAO Y, LI P, et al. TyG index performs better than HOMA-IR in Chinese type 2 diabetes mellitus with a BMI 35 kg/m 2: a hyperglycemic clamp validated study[J]. Medicina: Kaunas, 2022, 58(7): 876. DOI: 10.3390/medicina58070876.
|
| [12] |
SHI Y Y, ZHENG R, CAI J J, et al. The association between triglyceride glucose index and depression: data from NHANES 2005-2018[J]. BMC Psychiatry, 2021, 21(1): 267. DOI: 10.1186/s12888-021-03275-2.
|
| [13] |
ZHENG L, CUI C C, YUE S Q, et al. Longitudinal association between triglyceride glucose index and depression progression in middle-aged and elder adults: a national retrospective cohort study[J]. Nutr Metab Cardiovasc Dis, 2023, 33(3): 507-515. DOI: 10.1016/j.numecd.2022.11.015.
|
| [14] |
JIN M, LV P Y, LIANG H, et al. Association of triglyceride-glucose index with major depressive disorder: a cross-sectional study[J]. Medicine (Baltimore), 2023, 102(24): e34058. DOI: 10.1097/MD.0000000000034058.
|
| [15] |
WAN W T, YU Y. Association between the triglyceride glucose index and depression: a meta-analysis[J]. Front Psychiatry, 2024, 15: 1390631. DOI: 10.3389/fpsyt.2024.1390631.
|
| [16] |
ZHANG M, WANG B Y, LIU Y, et al. Cumulative increased risk of incident type 2 diabetes mellitus with increasing triglyceride glucose index in normal-weight people: the Rural Chinese Cohort Study[J]. Cardiovasc Diabetol, 2017, 16(1): 30. DOI: 10.1186/s12933-017-0514-x.
|
| [17] |
ZHU B R, WANG J, CHEN K, et al. A high triglyceride glucose index is more closely associated with hypertension than lipid or glycemic parameters in elderly individuals: a cross-sectional survey from the Reaction Study[J]. Cardiovasc Diabetol, 2020, 19(1): 112. DOI: 10.1186/s12933-020-01077-6.
|
| [18] |
SHI P F, FANG J B, LOU C Y. Association between triglyceride-glucose(TyG)index and the incidence of depression in US adults with diabetes or pre-diabetes[J]. Psychiatry Res, 2025, 344: 116328. DOI: 10.1016/j.psychres.2024.116328.
|
| [19] |
KEMP D E, SCHINAGLE M, GAO K M, et al. PPAR-γ agonism as a modulator of mood: proof-of-concept for pioglitazone in bipolar depression[J]. CNS Drugs, 2014, 28(6): 571-581. DOI: 10.1007/s40263-014-0158-2.
|
| [20] |
KESSING L V, RYTGAARD H C, EKSTRØM C T, et al. Antidiabetes agents and incident depression: a nationwide population-based study[J]. Diabetes Care, 2020, 43(12): 3050-3060. DOI: 10.2337/dc20-1561.
|
| [21] |
GONZALEZ J S, BEBU I, KRAUSE-STEINRAUF H, et al. Differential effects of type 2 diabetes treatment regimens on diabetes distress and depressive symptoms in the glycemia reduction approaches in diabetes: a comparative effectiveness study(GRADE)[J]. Diabetes Care, 2024, 47(4): 610-619. DOI: 10.2337/dc23-2459.
|
| [22] |
WIUM-ANDERSEN I K, OSLER M, JØRGENSEN M B, et al. Diabetes, antidiabetic medications and risk of depression-A population-based cohort and nested case-control study[J]. Psychoneuroendocrinology, 2022, 140: 105715. DOI: 10.1016/j.psyneuen.2022.105715.
|
| [23] |
|
| [24] |
KONG L, CHEN K, WOMER F, et al. Sex differences of gray matter morphology in corticolimbicstriatal neural system in major depressive disorder[J]. Psychiatr Res, 2013, 47(6): 733-739. DOI: 10.1016/j.jpsychires.2013.02.003.
|
| [25] |
LEE J M, KIM B S, CHO S J, et al. Differences in depressive symptom profile by age group in koreans with major depressive disorder: results from nationwide general population surveys[J]. Psychiatry Investig, 2024, 21(9): 1025-1032. DOI: 10.30773/pi.2024.0074.
|
| [26] |
LU J, XU X F, HUANG Y Q, et al. Prevalence of depressive disorders and treatment in China: a cross-sectional epidemiological study[J]. Lancet Psychiatry, 2021, 8(11): 981-990. DOI: 10.1016/S2215-0366(21)00251-0.
|
| [27] |
BENAVIDEZ G A, YLITALO K R, LANNING B, et al. Peripheral neuropathy and depressive symptoms: examining the association in a primary health care setting among persons with and without diabetes mellitus[J]. Qual Life Res, 2020, 29(12): 3297-3304. DOI: 10.1007/s11136-020-02579-2.
|
| [28] |
GHARAIBEH B, BANIYONES A, ABUHAMMAD S, et al. Depression among outpatients with diabetic peripheral neuropathy: prevalence and associated factors[J]. Future Sci OA, 2025, 11(1): 2458989. DOI: 10.1080/20565623.2025.2458989.
|
| [29] |
ZHU M M, LI Y W, LUO B Y, et al. Comorbidity of type 2 diabetes mellitus and depression: clinical evidence and rationale for the exacerbation of cardiovascular disease[J]. Front Cardiovasc Med, 2022, 9: 861110. DOI: 10.3389/fcvm.2022.861110.
|
| [30] |
AMARE A T, SCHUBERT K O, KLINGLER-HOFFMANN M, et al. The genetic overlap between mood disorders and cardiometabolic diseases: a systematic review of genome wide and candidate gene studies[J]. Transl Psychiatry, 2017, 7(1): e1007. DOI: 10.1038/tp.2016.261.
|